Back

Performance of the Illumina Infinium MethylationEPIC v.2 array with low DNA input from Swedish neonatal dry blood spots

Brander, G.; Karlsson, H.; Dalman, C.; Bybjerg-Grauholm, J.; Crowley, J. J.; Mataix-Cols, D.

2025-03-13 genetic and genomic medicine
10.1101/2025.03.10.25323486 medRxiv
Show abstract

The Swedish Phenylketonuria (PKU) screening biobank contains neonatal blood spots from over five million individuals born in Sweden since 1975, offering a unique research resource. While its value has been proven in several research areas, such as genetics, the feasibility of DNA methylation studies using archived dried blood spots remains uncertain. Here, we selected samples from seven random individuals born between 1985 and 2003 to evaluate the performance of the Illumina Infinium MethylationEPIC v2.0 array on DNA extracted from PKU blood spots. Despite DNA input quantities as low as 19.2 ng, probe call rates remained exceptionally high (mean 99.76% at p<0.01), with robust methylation site coverage across all samples. These findings challenge conventional assumptions about the DNA quantity and quality required for methylation arrays and demonstrate that decades-old neonatal blood spots can yield high-quality epigenetic data.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.